Farallon Capital Management’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $242K | Hold |
|
|||||
|
2025
Q1 | $218K | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $209K | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $16.5M | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $49.3M | Sell |
|
|||||
|
2021
Q1 | $129M | Hold |
|
|||||
|
2020
Q4 | $167M | Sell |
|
|||||
|
2020
Q3 | $193M | Buy |
|
|||||
|
2020
Q2 | $169M | Sell |
|
|||||
|
2020
Q1 | $155M | Buy |
|
|||||
|
2019
Q4 | $178M | Sell |
|
|||||
|
2019
Q3 | $149M | Buy |
|
|||||
|
2019
Q2 | $177M | Buy |
|
|||||
|
2019
Q1 | $177M | Buy |
|
|||||
|
2018
Q4 | $93.9M | Buy |
|
|||||
|
2018
Q3 | $103M | Hold |
|
|||||
|
2018
Q2 | $96.9M | Buy |
|
|||||
|
2018
Q1 | $84.2M | Buy |
|